The spurring demand for personalized medicine, increasing government initiatives and support, and decreasing cost of sequencing services will drive the genomics market at 12.7% CAGR during the forecast period (2020–2030).

The North American air quality monitoring (AQM) market is projected to attain a value of $2,628.5 million by 2024.

According to P&S Intelligence, the market was valued at $4.6 billion in 2017, and it is expected to reach $12.6 billion by 2023.

Osteoporosis drugs market at a CAGR of 3.8% in the forecast period (2016–2022). At this growth rate, the market size is expected to reach $11,482.1 million by 2022 from $8,835.4 million in 2015.

The global ventilator market is expected to generate a revenue of $1.0 billion by 2022, progressing at a 7.7% CAGR during the forecast period (2016–2022).

Additionally, such treatments are gradually gaining popularity among consumers in the region owing to the growing Western influence and desire to have a better appearance, particularly among women.

The auto-injectors market is predicted to progress at an 18.6% CAGR during the forecast period (2017–2023).

The global pulse and regional oximeters market reached a value of $2,101.0 million in 2018 and is expected to attain a value of $3,365.0 million in 2024, advancing at an 8.2% CAGR during the forecast period (2019–2024).

The global small joint reconstructive implants market is expected to generate $10.1 billion revenue by 2024, advancing at a CAGR of 5.5%, during the forecast period.

The global negative pressure wound therapy (NPWT) devices market had a valuation of $2,178.4 million in 2019.

The global photoacoustic imaging market reached a valuation of $39.8 million in 2019 and is predicted to generate a revenue of $279.3 million by 2030.

The global cleanroom doors market is expected to progress at a CAGR of 5.3% during the forecast period.

As per a P&S Intelligence report, the global blockchain in healthcare market is predicted to reach a value of $890.5 million by 2023, from $44.6 million in 2017, and is expected to advance at a 67.1% CAGR during the forecast period (2018–2023).

The global microfluidic devices market is predicted to grow explosively in the coming years, as per the estimates of the market research firm, P&S Intelligence.

Global image guided surgery devices market is expected to grow at a CAGR of 6.5%, during 2017 - 2023.

The medical aesthetics market stood at $8.6 billion in 2016, and it is projected to reach $19.4 billion by 2023, displaying a 12.2% CAGR during 2017–2023 (forecast period).

The transdermal drug delivery systems market is projected to grow from just over $30.0 billion in 2016, to more than $60.0 billion in size by 2023, at a CAGR of 9.8% during 2017–2023 (forecast period)

The U.S. pulse and regional oximeters market generated a revenue of $687.3 million in 2018 and is predicted to reach a value of $1,101.4 million in 2024, registering an 8.2% CAGR during the forecast period (2019–2024).

The European DOA testing market is forecasted to reach $3.0 billion by 2023, according to P&S Intelligence.

Global Nuclear Imaging Equipment Market is expected to grow at a CAGR of 4.8%, during 2017 - 2023.

Global medical display monitor market is expected to attain revenue of $2.8 billion by 2023, according to P&S Intelligence.

North American Patient Engagement Solutions Market to Register 15.8% CAGR during 2018–2023

The global dermatology drugs market is expected to advance rapidly during the forecast period (2018–2023).

During the forecast period (2015–2020), the global magnetic resonance imaging (MRI) compatible patient monitoring systems market is projected to witness a 3.1% CAGR.

On the basis of type, the peripheral I.V. catheter market is bifurcated into integrated/closed type and short type. In 2015, the larger revenue share in the market was accounted for by the short catheters.

Global nerve repair and regeneration market is expected to grow at a CAGR of 11.9% during 2017 - 2023.

The global energy-based aesthetic devices market attained a valuation of $2.6 billion in 2018 and is predicted to reach a value of $4.6 billion by 2024.

The global population health management market is predicted to generate a revenue of over $48.1 billion by 2022, and is expected to progress at a 23.3% CAGR during the forecast period (2016–2022), as per a study conducted by P&S Intelligence.

As per a report by P&S Intelligence, the global patient engagement solutions market is predicted to reach a value of $21.9 billion by 2023, from $8.5 billion in 2017, progressing at a 16.9% CAGR during the forecast period (2018–2023).

The global anatomic pathology market is expected to generate $24.3 billion revenue by 2024, advancing at a CAGR of 5.8% during the forecast period.

The global 3D bioprinting market is projected to reach a value of $792.5 million in 2022, witnessing a CAGR of 35.9% during the forecast period (2016–2022).

The global endoscope market was valued at $18.9 billion in 2018, which is projected to reach $28.4 billion by 2024, progressing at a CAGR of 7.2% during the forecast period (2019–2024).

The global CDSS Market was valued at $410.5 million in 2015, and it is expected to grow at a CAGR of 21.5% during 2016-2022.

The market is projected to generate revenue worth $10.4 billion in 2024, witnessing a CAGR of 7.1% during the forecast period (2019–2024).

The transdermal drug delivery systems market valued over $30.0 billion in 2016, and it is predicted to grow significantly, with a CAGR of around 10.0%, during 2017–2023 (forecast period).

Global IoT in healthcare market is projected to generate a revenue of $267.6 billion by 2023, increasing from $56.1 billion, exhibiting a 30.2% CAGR during the forecast period (2018–2023).

As per the Parkinson’s Disease Foundation, about 7–10 million people suffer from Parkinson’s disease, globally. In the U.S., each year, 60,000 new cases of Parkinson’s disease are reported.

The neurostimulation device market is expected to register a 12.9% CAGR during 2016–2022.

The global automated external defibrillator (AED) market was valued at $1,476.0 million in 2018 and is expected to reach $3,991.5 million by 2030, advancing at a CAGR of 8.8% during 2020–2030 (forecast period).

Global interventional radiology market generated a revenue of $19.0 billion and is expected to attain a value of $27.3 billion by 2024, advancing at a 6.4% CAGR during the forecast period (2019–2024).

The global endoscope market was valued at $18.9 billion in 2018, which is projected to reach $28.4 billion by 2024, progressing at a CAGR of 7.2% during the forecast period (2019–2024).

The North American air quality monitoring market is estimated to generate $1,590.7 million revenue in 2018 and is predicted to progress at a CAGR of 8.8% during 2019–2024.

Geographically, North America dominated the global market of CT in 2015; whereas the Asia-Pacific market is expected to witness the fastest growth, at a CAGR of 5.8%, during the forecast period.

The global surgical navigation system market generated a revenue of $770.8 million in 2018 and is expected to reach $1,167.6 million in 2024, advancing at a 7.3% CAGR during the forecast period (2019–2024).

Global medical display monitor market is expected to attain revenue of $2.8 billion by 2023, according to P&S Intelligence.

The global network connected medical devices market is expected to generate $66.6 billion revenue by 2024, advancing at a CAGR of 23.5% during the forecast period.

The global biobanking market is expected to generate $36.8 billion revenue by 2024, advancing at a CAGR of 6.2%, during the forecast period.

Thus, with the rising prevalence of cancer and fruitful R&D, the catalog peptides market is predicted to grow from $238.4 million in 2018 to $332.1 million by 2024, at a 5.8% CAGR during 2019–2024 (forecast period).

Global Aspiration and Biopsy Needles Market Set to Generate Over $1,500.0 Million Revenue by 2030

The global biosensors market was valued at $14,169.5 million in 2015, and it is expected to grow at a CAGR of 9.8% during 2016-2022.